| UHC Commercial Medical & Drug | Cell-Free Fetal DNA Testing - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC Commercial Medical & Drug | Gene Therapies for Hemophilia B - Commercial Medical Benefit Drug Policy | 2026-01-02 |
| UHC Commercial Medical & Drug | Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan - Site of Service - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC UMR Medical and Drug | Cardiovascular Disease Risk Tests - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC UMR Medical and Drug | Cell-Free Fetal DNA Testing - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC UMR Medical and Drug | Gene Therapies for Hemophilia B - Commercial Medical Benefit Drug Policy | 2026-01-02 |
| UHC UMR Medical and Drug | Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan - Site of Service - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC Surest Medical and Drug | Cardiovascular Disease Risk Tests - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC Surest Medical and Drug | Cell-Free Fetal DNA Testing - Commercial and Individual Exchange Medical Policy | 2026-01-02 |
| UHC Surest Medical and Drug | Gene Therapies for Hemophilia B - Commercial Medical Benefit Drug Policy | 2026-01-02 |